Blue-chip medical facilities utilizing the iMedHD2™ Mobile-Cart Solution are seeing an enhanced workflow with a significant return on their investments.
MELVILLE, NY. (PRWEB) October 30, 2018
Remote Medical Technologies (RMT) will be participants at the American Society of Cytopathology’s (ASC) 2018 66th Annual Scientific Meeting being held in Washington, DC on November 11th and 12th. The highly acclaimed iMedHD2™ Mobile-Cart and Scope Solution s, as well as the accompanying RMTConnect™ application for iOS and Android, will be exhibited at the meeting. These solutions contain the features and benefits of a high-performance HD telecytology solution that allows users to securely share cytology images directly from any microscope in dynamic, live, real-time (with absolutely no scanning required) to many remote cytopathologists. RMT has cleverly combined their telepathology technology with a purpose-built mobile cart, and industrial strength wireless connectivity, for rapid on-site evaluations (ROSE). So clever, that RMT clientele are highlighting the fiscal and operational benefits in a scheduled workshop open for all ASC attendees. These two highly-reputable facilities have implemented an astonishing number of adequacies and have seen a significant return on their investment since incorporating RMT into their daily workflows and are showcasing this information in a highly anticipated lecture scheduled during the event.
RMT’s iMedHD2™ is widely known for being the most mobile telecytology technology on the market. This application gives users the ability to quickly and securely participate in live, dynamic streaming of HD video and audio sessions from their PC, MAC, iPhone™ or iPad™. Moderators allow guest participants to join a session, jointly annotate images, and record snapshots and movies for instant image sharing and decision-making among collaborating experts. RMT is the only provider in the industry that allows for highly secure, live, real-time image and video streaming. They will be proving once again that they are always steps ahead by giving a “sneak peek” into their next generation of telecytology. This unveiling will give users a preliminary view into future performance, image quality, and security benefits of telecytology.
RMT Founder and CEO, Don Marchon, adds, “RMT does so much more than provide a ‘one-size-fits-all’ telepathology solution. We believe that our clients' success drives RMT success. We tailor each implementation to meet the mission-critical requirements of that medical organization. Successful results are evident in our clients' validated findings.” Blue-chip medical facilities utilizing the iMedHD2™ Mobile-Cart Solution are seeing an enhanced workflow with a significant return on their investments. These results have been repeatedly proven and published in several medical journals throughout the year. The iMedHD2™ purpose-built technology improves patient outcomes and increases medical facility revenue while significantly reducing costs.
Visit RMT at booth #100 at the Omni Shoreham Hotel for the 66th Annual Scientific Meeting to receive a hands-on demonstration and learn more about how your medical facility could benefit from this state-of-the-art technology.
About Remote Medical Technologies, LLC.
Remote Medical Technologies is the creator of an innovative patented technology for delivery of Internet-based premium telemedicine services. The company is a Limited Liability Corporation headquartered in New York. RMT provides a best-in-class web-based video, voice, collaboration and administration platform. With merely the use of a browser, the solution is easy to deploy, operate and manage. This customizable and extendable multimedia services platform is a modular, non-fragmented approach to extending a healthcare organization’s communications infrastructure. Be it across the street or around the globe, RMT drives telemedicine concepts and provides solutions that save lives.